LOVE Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Cannara Biotech Inc

Watchlist Manager

Watchlist

Price: 1.99 CAD 0.51%

Market Cap: CA$196.6m

	Cannara Biotech Inc TSX:LOVE	CA
	Trevi Therapeutics Inc NASDAQ:TRVI	US
	Lithium Universe Ltd OTC:LUVSF	AU
B	Bestsun Energy Co Ltd SSE:600681	CN
	ENGlobal Corp OTC:ENGCQ	US
H	High Velocity Alternative Energy Corp OTC:RKTE	US
T	Telecard Ltd KAR:TELE	PK
F	Fraser and Neave Ltd F:FNV2	SG
	ECS Botanics Holdings Ltd ASX:ECS	AU
S	Strix Group PLC SWB:SG9	IM
E	Eastern Metals Ltd ASX:EMS	AU
G	Genovate Biotechnology Co Ltd TPEX:4130	TW
	Drone Volt SA F:2DV0	FR
E	Emco Industries Ltd KAR:EMCO	PK
	Almado Inc TSE:4932	JP

Profitability Summary

Cannara Biotech Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

18%

Sustainable 3Y Average Gross Margin

11%

Gross Margin is Increasing

11% > 18%

Negative Operating Margin

-7%

Negative 3Y Average Operating Margin

-14%

Operating Margin is Increasing

-16% > -7%

Healthy Net Margin

11%

Sustainable 3Y Average Net Margin

11%

Declining Net Margin

12% > 11%

Exceptional Free Cash Flow Margin

12%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

-6% > 12%

Positive ROE

12%

Positive 3Y Average ROE

Negative 3Y Average ROIC

-10%

ROIC is Increasing

-8% > -4%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.